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Because of the importance of human cells, particularly 
human epithelial cells, in cancer research, we have studied 
certain phases or events of carcinogenesis using human epi­
dermal cells in primary culture. 1) We found that human 
epidermal cells are capable of metabolizing benzo[a]pyrene. 
Large inter-individual variations are found in the basal and 
induced aryl hydrocarbon-hydroxylase activities. 2) UV -in­
duced unscheduled DNA synthesis was demonstrated in 
human epidermal cells on autoradiographs. We also found 
that DNA repair is defective in epidermal cells isolated from 
xeroderma pigmentosum by a new explant-outgrowth cul­
ture. 3) Human epidermal cells are unique in that there is a 
large number of binding sites to phorbol esters compared 
I ncreasing emphasis is being placed on the use of human mate­rials in cancer research. Because human in vivo studies other than epidemiologic and clinical ones are impossible, the use of cultured human cells is the most promising way to obtain information on the etiology and biology of human cancers. 
Because of the importance of human cells, particularly human 
epithelial cells, we have started a project on the use of human epi­
dermal cells in studies of carcinogenesis. We chose epidermal cells 
because they can be obtained relatively easily during plastic surgery 
and because techniques for epidermal-cell culture have been well 
established. Furthermore, epidermal cells show terminal differen­
tiation, reorganizing to form a multilayered epidermal sheet, and 
this process offers unique opportunities for investigating cellular 
differentiation and carcinogenesis. 
Isolation and Cultivation of Epidermal and Dermal Cells 
from Human Skin Skin sections approximately OA-mm thick 
cut with a dermatome were obtained from material discarded during 
skin graftings. The skin layer was cut into small pieces and incu­
bated with 0.25% trypsin solution overnight at 4 ° C. The epidermis 
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Abbreviations: 
AHH: arylhydrocarbon hydroxylase 
BDBU: phorbol-12-13-dibutyrate 
BP: benzo[a]pyrene 
EGF: epidermal growth factor 
ODC: ornithine decarboxylase 
SCC: squamous cell carcinoma 
TP A: 12-0-tetradecanoyl phorbol-13-acetate 
UDS: unscheduled DNA synthesis 
XP: xeroderma pigmentosum 
with mouse epidermal cells, but there is no down-regulation. 
Further, human epidermal cells show essentially negative 
responses to tumor promoters, i.e., no stimulation of DNA 
synthesis, sugar uptake, and no induction of ornithine decar­
boxylase activity. 4) Human epidermal cells contain 1.5 X 
105 binding sites per cell for epidermal growth factor (EGF), 
whereas squamous cell carcinomas of skin and oral cavity 
have larger amounts ofEGF receptors in the order of 106 per 
cell. 5) Based on the above results, we attempted to transform 
human epidermal cells by the treatment with chemical car­
cinogens, but until now no transformation was obtained. 
] Invest DermatoI92:271S-274S, 1989 
was separated from the dermis with forceps. Epidermal cells were 
isolated from the epidermis sheets, while dermal fibroblasts were 
separated from the dermis by further trypsinization at 37°C for 30 
min. The epidermal cells were grown in Eagle's minimum essential 
medium supplemented with 10% or 20% fetal calf serum at 37°C 
under 5% CO2 in air. Further details were reported elsewhere [1 ]. 
We also used a new method of explant-outgrowth culture for 
biopsy specimens, as described later. 
Cultures of epidermal cells consisted of tightly packed polygonal 
cells with a characteristic epithelial appearance. Some melanocytes 
were scattered singly in the sheets of epidermal cells, but scarcely 
any fibroblasts were found in the primary cultures (Fig lA). 
Many optimal culture conditions have been reported for the iso­
lation and cultivation of epidermal cells. In our experience, the 
addition of cholera toxin and epidermal growth factor (EGF) 
greatl y enhanced the growth of epidermal cells [2,3]. The growth of 
epidermal cells is considerably improved by plating on a feeder layer 
of irradiated 3T3 cells or C3HI0Tl/2 cells [3]. However, feeder 
cells were not used in the present study to avoid complications from 
the presence of living cells from another source. 
Benzo[a]pyrene Metabolism in Human Epidermal Cells Be­
cause they are located on the surface of the body, epidermal cells are 
exposed to sunlight and environmental carcinogens. Benzo[a]py­
rene (BP) and other polycyclic aromatic hydrocarbons are prevalent 
contaminants in the air, water, and soil. 
We found that human epidermal cells are capable of metaboliz­
ing BP [1 ,4-6]. Analysis of BP metabolites by high-performance 
liquid chromatography indicated that epidermal cells metabolize 
BP preferentially at non-K-regions, such as positions 7 -10, form­
ing a precursor of the ultimate metabolite, BP-7, 8-dihydrodiol-
9,1 O-epoxide. The metabolic activity was further demonstrated by a 
cell-mediated assay, in which V79 Chinese hamster cells were co­
cultured on top of sheets of human epidermal cells and treated with 
BP for 48 h for induction of mutagenesis [1 ,4,5]. 
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Figure 1. Phase-contrast picture of human epidermal cells. 
The most striking observation was that human epidermal cells 
did activate BP to a form that was mutagenic to co-cultured V79 
cells, but not dermal fibroblasts (Fig 2). In contrast, mouse fibro­
blasts activated BP and induced mutation in co-cultured V79 cells, 
indicating interspecies variation in metabolic activation of BP be­
tween human and mouse fibroblasts [5). 
Subsequently, we measured activity of aryl hydrocarbon hydrox­
ylase (AHH), which metabolizes BP, of cultured epidermal and 
dermal cells with and without induction by 13.uM benz[a)anthra­
cene for 24 h [6). As shown in Fig 3, large inter-individual variations 
were found in the basal (mean: 3.9 units; SO: 4.2; range: 0-16.3) 
and induced AHH activities (mean: 97.4 units; SO: 69.4; range: 
2.7 -216.9) and the induction ratio (mean: 51.1 ;  SO: 63.0; range: 
0.6-262.0) (one unit was defined as 1 pmol of 3-hydroxy BP 
formed/mg protein/h). The basal and induced AHH activities of 
dermal fibroblasts were both lower than epidermal cells and distrib­
uted in a narrow range. 
A major question about AHH activity and its inducibility is the 
relation of these factors to carcinogenesis. Kellermann et al [7) re­
ported that the increased inducibility in cultured lymphocytes is 
associated with susceptibility to bronchogenic cancer, although this 
observation evoked much controversy. Follow-up of the donors in 
the present study will be interesting. 
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Figure 2. Induction of mutations in cell-mediated mutation assay in which 
BP was activated by human cells (left) or rodent cells (right) [5]. A: Human 
cell mediated assays in which epidermal cells (closed circle), dermal fibroblasts 
(open circle), and IMR-90 fibroblasts (open square) were used as an activating 
layer. B: Rodent cell-mediated assays in which epidermal cells (closed circle) 
and dermal fibroblasts (open circle) isolated from newborn C3H mice and rat 
embryo fibroblasts (opell square) were used as the activating layer. Mutation 
in co-cultured V79 Chinese hamster cells, measured by resistance to 1 mM 
ouabain, is expressed as the number of resistant colonies per 105 survivors. 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
.. 2 
tI 
u 
o 
II> 
.a 
E 8 
Z 6 
4 
2 
o 
A 
20 
Activity [ unit I 
B 
Activity [ unll I 
Induction Ratio 
Figure 3. Frequency distribution of basal AHH activiry (A), induced AHH 
activity (B), and the induction ratio (C) in 29 human epidermal cell cultures 
[6]. 
UV-Induced Unscheduled DNA Synthesis in Human Epi­
dermal and Dermal Cells Sunlight is the primary stimulus for 
most human skin cancers. Despite the fact that epidermal cells are a 
target of UV -carcinogenesis, most information on DNA repair has 
been obtained from studies on cultured dermal fibroblasts. We mea­
sured UV-induced unscheduled DNA synthesis (UOS) of human 
epidermal cells on autoradiographs [8). UOS was induced dose­
dependently at doses of 5 to 20 1/m2 to almost the same extent as 
mouse epidermal cells. In human dermal cells, the number of grains 
was about 3.3 times that in epidermal cells. 
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Figure 4. Dose-dependent induction of UDS by UV irradiation in normal 
and XP epidermal cells [9]. The range of UDS in normal epidermal cells is 
indicated by the shaded area. XP epidermal cells were isolated from patients of 
XP-A (closed circle), XP-E (open circle), and the XP-variant (closed triangle). 
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Xeroderma pigmentosum (XP) is a rare, autosomal recessive dis­
ease characterized by a high frequency of skin cancers and defect in 
excision repair of UV -induced DNA damages. We developed a new 
method for explant-outgrowth culture of epidermal cells from 
small biopsy specimens by which we could measure DNA repair of 
XP epidermal cells [9). We found that cultured epidermal cells from 
XP patients had a defect in UDS induced by UV-irradiation, 
the extent being dependent on a complementary group of XP, 
but being the same as their dermal counterparts within the group 
excepting XP variants (Fig 4). 
Binding and Actions of Phorbol Ester Tumor Promoters in 
Human Epidermal Cells The process of tumor promotion has 
been studied in detail in mouse skin with phorbol ester tumor pro­
moters isolated from croton oil, e.g., 12-0-tetradecanoylphorbol-
13-acetate (TPA). Although there have been many studies in TPA 
and other tumor promoters, in almost all of them nonhuman mate­
rials, mostly mouse cells, were used. 
We demonstrated the presence of specific binding sites for phor­
bol esters in human epidermal and dermal cells in culture by assay of 
binding of [3H) phorbol-12,13-dibutyrate (PDBU) to intact cells 
[10). Human epidermal cells bound PDBU with Kd of28 nM and a 
Nmax of 3.7 X 106 molecules per cell, while human dermal cells 
bound PDBU with a Kd of 27 nM and a Nmax of 2.1 X 106 mole­
cules per cell (Fig 5). Although mouse cells showed the same affin­
ity as human cells, mouse epidermal cells bound one-third as much 
as human epidermal cells, and mouse dermal cells bound one-fifth as 
much as human dermal cells. When precultured with unlabeled 
PDBU for 24 h, (3H)PDBU binding decreased time dependently in 
all cells except human epidermal cells (Fig 6). Thus, the binding of 
phorbol esters to human epidermal cells is unique in that there is a 
large number of binding sites compared with mouse epidermal cells, 
and there is no down regulation. 
We further studied biologic and biochemical responses of human 
epidermal cells exposed to TPA [11 ). TPA inhibited DNA synthesis 
and sugar transport, and did not induce ornithine decarboxylase 
(ODC) activity, a key enzyme in polyamine synthesis. Because of 
these essentially negative responses, the effects of TP A on human 
dermal and mouse epidermal and dermal cells were also studied for 
comparison. These cells were found to behave differently from 
human epidermal cells in at least one way. These findings seem to 
cast some doubt on the possibility that phorbol esters act as a tumor 
promoter in human skin. In contrast, however, Verma et al [12) 
reported the induction in vitro of ODC by TPA in human-skin 
biopsy specimens incubated in serum-free Eagle's minimum essen­
tial medium. The possible cause of the difference in this and our 
studies is unclear. 
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Figure 5. Scatchard plot analysis of specific binding of[3H)PDBU to intact 
cells [to). Line A (closed circle): human epidermal cells; Line B (open circle): 
human dermal cells; Line C (closed square): mouse epidermal cells; Line D 
(open square): mouse dermal cells. Inset: plots of Lines C and D. 
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Figure 6. Down regulation of [3H)PDBU binding in human epidermal 
cells (closed circle), human dermal cells (open circle), mouse epidermal cells 
(closed square), and mouse dermal cells (open square) [to). After preincubation 
with 30 nM unlabeled PDBU at 37"C for 2 to 24 h, bound PDBU was 
removed, followed by binding assay. 
Possible Role ofEGF Receptor in Carcinogenesis ofEpider­
mal Cells Growth of human epidermal cells is enhanced by treat­
ment with EGF. The effect of EGF is mediated by a cell surface 
receptor with a molecular weight of 170,000 that shows tyrosine­
specific protein kinase activity and is coded by the proto-erb B 
oncogene. 
We studied the role of EGF and its receptors in carcinogenesis 
using epidermal cells and their malignant counterparts, squamous 
cell carcinoma (SCC) cells [13,14). EGF inhibited the growth and 
colony formation of all SCC cells at doses that are mitogenic in 
epidermal cells and dermal fibroblasts. This inhibitoty effect was 
specific because EGF did not inhibit, and in some cases slightly 
stimulated, the growth of other tumor cells. 
The amount of EGF receptors on SCC cells was measured by a 
binding assay of membrane preparations using 125I-EGF (Table I). 
Of 13 SCC cell cultures tested, all except three of esophageal SCC 
showed higher levels of EGF receptor than normal epidermal cells, 
which contain 1 .5 X 105 binding sites per cell. In general, SCCs of 
the skin and oral cavity had large amounts of EGF receptor in the 
order of 106 per cell. The values for the equilibrium dissociation 
constant (Kd) of these cells were on the order of nM. Amplification 
of erb B gene was also noted in SCC cell lines by "Southern" 
blotting assay. Sensitivity to the inhibitory effect of EGF correlated 
Table I. EGF Receptors in Epidermal Cells and SCCs of the 
Skin, Oral Cavity, and Esophagus' 
N max 
Kd Sites per Ratio to 
Cells SCC of (nM) Cell (XtOS) Epidermal Cells 
Epidermal cells 2.5 1.5 1.0 
A431 Vulva 5.0 36 24.0 
HSC-l Skin 5.3 79 52.6 
HSC-2 Oral cavity 5.4 73 48.7 
HSC-3 Oral cavity 4.1 5.6 3.7 
HSC-4 Oral cavity 3.2 21 14.0 
Ca9-22 Oral cavity 4.3 28 18.7 
NA Oral cavity 5.8 67 44.6 
ZA Oral cavity 4.0 10 6.7 
TE-l Esophagus 3.2 6.3 4.2 
TE-2 Esophagus 2.1 1.0 0.7 
TE-3 Esophagus 6.1 1.4 0.9 
TE-4 Esophagus 5.8 1.2 0.8 
TE-8 Esophagus 4.2 6.2 4.1 
• Reference 14. 
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Figure 7. Attempts to transform human epidermal cells by the treatment 
with BP and TPA. Concentration of TPA was increased stepwise up to 
100 ng/ml. EP Focus: focus of epithelial cells. 
well with the elevated level of EGF receptors in 12 SCC cell lines. 
The present observations suggest that EG F and EG F receptors play a 
role in carcinogenesis of epidermal cells. 
Attempts to Transform Human Epidermal Cells by Chemi­
cal Carcinogens One object of our studies is to transform human 
epidermal cells by chemical carcinogens. On the basis of the above 
knowledge, we have attempted to transform human epidermal cells 
in vitro with BP and TPA (Fig 7 ). We used TPA because it stimu­
lates terminal differentiation, thus allowing the growth of undiffer­
entiated cells, although TPA itself may have no promoting activity 
on human epidermal cells, as described above. With time of cultiva­
tion, most epidermal cells were sloughed off into the medium as a 
result of terminal differentiation, and foci of slowly growing epi­
dermal cells appeared in two of three cultures after 1 10 or 170 d in 
culture. However, these epithelial foci were eventually occupied by 
fibroblastic cells. Thus, we have not yet succeeded in obtaining 
chemical transformation in vitro of human epidermal cells (unpub­
lished data). 
CONCLUDING REMARKS 
Carcinogenesis studies using human tissues and cells offer unique 
opportunities. Extrapolation of carcinogenesis data and knowledge 
of its mechanisms from laboratory animal to human may be 
achieved by comparative studies using cells derived from humans 
and rodents. In the present series of studies, we found that human 
epidermal cells are very similar to mouse epidermal cells in terms of 
metabolism of BP and DNA repair of UV-induced damages, but 
they are unique in the binding and the responses to phorbol ester 
tumor promoters. These differences may be explained in the near 
future by regulation of gene expression. 
Another characteristic of human cells is the lack of spontaneous 
transformation in vitro, which is possibly related to their chromo­
somal stability. In vitro transformation of human cells has proved to 
be much more difficult than that of rodent cells. Although several 
groups succeeded in obtaining neoplastic transformation of human 
fibroblasts, these experiments are not necessarily repeatable. Fur­
thermore, fewer investigators have studied transformation of 
human epithelial cells (for review, see Ref 15). Yoakum et al [16] 
reported that transfection of v-Ha-ras oncogene transformed 
human bronchial epithelial cells, which may be due to enhanced 
genetic instability mediated by transfected ras, rather than direct 
actions of the ras gene product [15]. In our study, we found amplifi-
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cation and overexpression of erb B gene in SCC cell lines, suggest­
ing possible involvement of erb B gene in carcinogenesis of epider­
mal and epithelial cells. We expect that human epithelial cells will 
be used for studies of oncogene-induced transformation, thus pro­
viding experimental evidence for causes of human cancers. 
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